Ladenburg Thalmann Financial Services’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$6K Buy
90
+25
+38% +$1.67K ﹤0.01% 4729
2019
Q3
$7K Hold
65
﹤0.01% 4560
2019
Q2
$6K Hold
65
﹤0.01% 4663
2019
Q1
$6K Hold
65
﹤0.01% 4602
2018
Q4
$4K Sell
65
-50
-43% -$3.08K ﹤0.01% 4702
2018
Q3
$14K Hold
115
﹤0.01% 4120
2018
Q2
$14K Hold
115
﹤0.01% 4066
2018
Q1
$14K Buy
+115
New +$14K ﹤0.01% 4066
2017
Q4
Sell
-50
Closed -$7K 5138
2017
Q3
$7K Buy
+50
New +$7K ﹤0.01% 4270